References

Unresolved reference

2021 · External reference

Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

10.1186/s12933-018-0728-6 · 2018 · External reference

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

10.1046/j.1464-5491.2002.00835.x · 2002 · External reference

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

10.1056/nejmoa012512 · 2002 · External reference

The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity

10.2337/diacare.26.12.3230 · 2003 · External reference

Effect of weight loss with lifestyle intervention on risk of diabetes

10.2337/dc06-0560 · 2006 · External reference

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin

10.2337/diabetes.54.8.2404 · 2005 · External reference

Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study

10.2337/dc07-1117 · 2008 · External reference

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

10.7326/0003-4819-142-8-200504190-00009 · 2005 · External reference

Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial

10.1016/s2213-8587(16)30162-0 · 2016 · External reference

Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over

10.1007/s13679-017-0262-y · 2017 · External reference

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

10.2337/diacare.20.4.537 · 1997 · External reference

Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study

10.1016/s2213-8587(19)30093-2 · 2019 · External reference

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study

10.1016/s2213-8587(14)70057-9 · 2014 · External reference

Forty-four years of the UK Prospective Diabetes Study: legacy effect and beyond

10.17925/ee.2025.21.1.8 · 2025 · External reference

Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)

10.1016/s0140-6736(24)00537-3 · 2024 · External reference

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

10.1056/nejm200105033441801 · 2001 · External reference

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

10.1016/s0140-6736(08)60766-7 · 2008 · External reference

Empagliflozin in heart failure with a preserved ejection fraction

10.1056/nejmoa2107038 · 2021 · External reference

Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications

10.1001/jama.2014.5988 · 2014 · External reference

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes

10.2337/dc10-2415 · 2011 · External reference

Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program

10.1161/circulationaha.106.679779 · 2007 · External reference

Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss

10.1016/j.jacc.2008.12.068 · 2009 · External reference

Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association

10.1161/cir.0000000000000450 · 2016 · External reference

Insulin resistance and incident heart failure: a meta-analysis

10.1002/ejhf.2531 · 2022 · External reference

Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial

10.1001/jama.2015.17346 · 2016 · External reference

The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction

10.1093/cvr/cvaf056 · 2025 · External reference

Good news from the Da Qing Diabetes Prevention Outcome Study—healthy lifestyles result in long-term cardiovascular benefits

10.21037/atm.2019.08.123 · 2019 · External reference

Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study

10.2337/dc11-1299 · 2012 · External reference

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

10.1016/s0140-6736(06)69701-8 · 2006 · External reference

Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study

10.1016/s2213-8587(15)00291-0 · 2015 · External reference

Effects of long-term metformin and lifestyle interventions on cardiovascular events in the Diabetes Prevention Program and its outcome study

10.1161/circulationaha.121.056756 · 2022 · External reference

Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study–secondary analysis of the randomized trial

10.1371/journal.pone.0005656 · 2009 · External reference

Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity

10.1016/j.cmet.2016.02.005 · 2016 · External reference

Prevalence of obesity and associated complications in China: a cross-sectional, real-world study in 15.8 million adults

10.1111/dom.15238 · 2023 · External reference

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study

10.1186/s12889-022-14912-0 · 2023 · External reference

Weight loss and metabolic benefits of bariatric surgery in China: a multicenter study

10.1111/1753-0407.13430 · 2023 · External reference